Pdt Partners, LLC Illumina, Inc. Transaction History

Pdt Partners, LLC

$1.02 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$92.79 - $142.53 $810,891 - $1.25 Million	-8,739 Reduced 75.34%	2,861 $398,000
Q3 2023 Nov 14, 2023	SELL	$128.91 - $192.44 $490,373 - $732,041	-3,804 Reduced 24.69%	11,600 $1.59 Million
Q2 2023 Aug 14, 2023	BUY	$183.43 - $232.67 $2.2 Million - $2.79 Million	11,993 Added 351.6%	15,404 $2.89 Million
Q1 2023 May 15, 2023	BUY	$193.75 - $232.55 $660,881 - $793,228	3,411 New	3,411 $793,000
Q4 2021 Feb 14, 2022	SELL	$347.28 - $421.83 $3.96 Million - $4.81 Million	-11,400 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$405.61 - $524.84 $689,537 - $892,228	1,700 Added 17.53%	11,400 $4.62 Million
Q2 2021 Aug 16, 2021	SELL	$372.84 - $481.5 $187,538 - $242,194	-503 Reduced 4.93%	9,700 $4.59 Million
Q1 2021 May 17, 2021	SELL	$361.28 - $504.76 $2.14 Million - $2.98 Million	-5,912 Reduced 36.69%	10,203 $3.92 Million
Q4 2020 Feb 16, 2021	SELL	$292.7 - $370.96 $1.99 Million - $2.52 Million	-6,785 Reduced 29.63%	16,115 $5.96 Million
Q3 2020 Nov 16, 2020	BUY	$268.51 - $400.74 $6.15 Million - $9.18 Million	22,900 New	22,900 $7.08 Million
Q2 2020 Aug 14, 2020	SELL	$256.46 - $373.01 $307,752 - $447,612	-1,200 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$209.2 - $335.53 $3.14 Million - $5.03 Million	-15,001 Reduced 92.59%	1,200 $328,000
Q4 2019 Feb 14, 2020	SELL	$288.29 - $335.49 $3.98 Million - $4.63 Million	-13,803 Reduced 46.0%	16,201 $5.38 Million
Q3 2019 Nov 14, 2019	BUY	$266.84 - $378.23 $1,067 - $1,512	4 Added 0.01%	30,004 $9.13 Million
Q2 2019 Aug 14, 2019	SELL	$300.59 - $368.15 $901 - $1,104	-3 Reduced 0.01%	30,000 $11 Million
Q1 2019 May 15, 2019	BUY	$272.57 - $321.18 $8.18 Million - $9.64 Million	30,003 New	30,003 $9.32 Million

Others Institutions Holding ILMN

# of Institutions

900

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $20.6B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account